- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Lenvatinib
Total 499 results
-
Memorial Sloan Kettering Cancer CenterCompletedHead and Neck Cancer | Head and Neck Squamous Cell Carcinoma | Head and Neck Carcinoma | Cutaneous Squamous Cell CarcinomaUnited States
-
Regina Elena Cancer InstituteUniversity of Pisa; University of Roma La Sapienza; University of Turin, Italy; Istituto Oncologico Veneto IRCCS and other collaboratorsRecruitingDifferentiated Thyroid Cancer | GenderItaly
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruitingAdvanced Hepatocellular Carcinoma (HCC)Italy, Poland, Singapore, China, Ukraine
-
Shandong New Time Pharmaceutical Co., LTDRecruitingHepatocellular CarcinomaChina
-
CStone PharmaceuticalsActive, not recruitingHepatocellular CarcinomaSpain, China, United States, Poland, Italy, Taiwan
-
Cancer Institute and Hospital, Chinese Academy...Active, not recruitingHepatocellular Carcinoma | Radiotherapy | LenvatinibChina
-
Fudan UniversityActive, not recruitingHepatocellular CarcinomaChina
-
Shanghai Zhongshan HospitalCompletedCholangiocarcinoma, IntrahepaticChina
-
Eisai Inc.Merck Sharp & Dohme LLCCompletedSolid TumorsUnited States, China, Belgium, Australia, Italy, Korea, Republic of, Germany, Netherlands, Poland, Romania, Thailand
-
Eisai Inc.CompletedThyroid CancerUnited States, Australia, France, Poland, United Kingdom, Italy
-
Peking Union Medical College HospitalSun Yat-Sen Memorial Hospital of Sun Yat-Sen University; The Second Affiliated...RecruitingRecurrent Ovarian CarcinomaChina
-
Massachusetts Eye and Ear InfirmaryEisai Inc.RecruitingAdvanced Cancer | Differentiated Thyroid CancerUnited States
-
National University Hospital, SingaporeEisai Co., Ltd.; Tan Tock Seng HospitalUnknown
-
Mirror Biologics, Inc.Immunovative (Thailand) Co., LtdRecruiting
-
Tianjin Medical University Cancer Institute and...Recruiting
-
Tianjin Medical University Cancer Institute and...Not yet recruitingResectable Hepatocellular Carcinoma
-
AkesoAkeso Pharmaceuticals, Inc.CompletedHepatocellular CarcinomaChina
-
Shanghai Zhongshan HospitalSun Yat-sen University; Eastern Hepatobiliary Surgery HospitalNot yet recruitingHepatocellular CarcinomaChina
-
Peking Union Medical College HospitalCompletedCholangiocarcinoma | Biomarker | Combinational Immunotherapy | Liver Neoplasm Malignant PrimaryChina
-
Tianjin Medical University Second HospitalRecruiting
-
Second Affiliated Hospital of Guangzhou Medical...Not yet recruitingHepatocellular Carcinoma Non-resectableChina
-
Peking Union Medical College HospitalRecruitingCadonilimab and LenvatinibChina
-
Sun Yat-sen UniversityRecruitingClear Cell Renal Cell Carcinoma | Neoadjuvant Therapy | CadonilimabChina
-
Sun Yat-sen UniversityNot yet recruitingRenal Cell CarcinomaChina
-
Second Affiliated Hospital of Guangzhou Medical...Recruiting
-
Hunan Province Tumor HospitalRecruitingSmall Cell Lung CancerChina
-
Shanghai Henlius BiotechNot yet recruitingAdvanced Hepatocellular Carcinoma
-
Northern Jiangsu People's HospitalNot yet recruitingHCC - Hepatocellular Carcinoma
-
3D Medicines (Sichuan) Co., Ltd.RecruitingAdvanced Endometrial CancerChina
-
Fudan UniversityCompletedIntrahepatic CholangiocarcinomaChina
-
Eisai Co., Ltd.Completed
-
Sun Yat-sen UniversityUnknownHepatocellular CarcinomaChina
-
Qilu Pharmaceutical Co., Ltd.Not yet recruitingAdvanced Renal Cell Carcinoma
-
Hunan Province Tumor HospitalRecruitingSmall-cell Lung CancerChina
-
Tianjin Medical University Cancer Institute and...Not yet recruitingResectable Hepatocellular CarcinomaChina
-
Yunfei YuanRecruitingHepatocellular Carcinoma | Transarterial ChemoembolizationChina
-
Tianjin Medical University Cancer Institute and...Not yet recruitingObjective Response Rate (ORR)
-
RenJi HospitalNot yet recruitingLiver Transplantation | Hepatocellular Carcinoma | Portal Vein Tumor Thrombus
-
Eisai Inc.TerminatedThyroid Carcinoma, AnaplasticItaly, United States, France, Australia, United Kingdom
-
Eisai Inc.Completed
-
Hadassah Medical OrganizationRecruiting
-
Shanghai Zhongshan HospitalActive, not recruitingBiliary Tract Cancer | PD-1 Antibody | Lenvatinib | GemoxChina
-
Eisai Inc.CompletedThyroid CancerUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, Denmark, France, Germany, Italy, Japan, Korea, Republic of, Poland, Portugal, Romania, Russian Federation, Spain, Sweden, Thailand, United Kingdom
-
Fujian Provincial HospitalRecruiting
-
RenJi HospitalRecruitingHepatocellular CarcinomaChina
-
Tianjin Medical University Cancer Institute and...RecruitingResectable Hepatocellular CarcinomaChina
-
Sichuan UniversityNot yet recruitingCarrelizumab Plus Lenvatinib Combined With TACE | Borderline Resectable Hepatocellular CarcinomaChina
-
Assistance Publique - Hôpitaux de ParisEisai Inc.Active, not recruitingHepatocellular CarcinomaFrance
-
Eisai Inc.Quintiles, Inc.CompletedNon-Small Cell Lung CancerBelgium, Korea, Republic of, Italy, United States, Hungary, United Kingdom, Czechia
-
Chang Gung Memorial HospitalMinistry of Health and Welfare, TaiwanRecruitingHigh Risk of RecurrenceTaiwan